Ahmedabad (Gujarat) [India], September 25: Intas Pharmaceuticals Limited ("Intas") has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending approval of HETRONIFLY® (serplulimab, approve
Texas [US], November 26 (ANI): Around a decade ago the first checkpoint inhibitor drugs were developed to treat cancer and studies have been going on to make them more effective. According to a new research, the over-the-counter second-generation antihistamines might be able to improve the o
Connecticut [US], May 21 (ANI): A team of scientists discovered novel immune checkpoints that have applications for cancer, autoimmune disease treatment. The immune system is a complex balancing act; if it overreacts or underreacts to foreign molecules, there can be serious health consequenc